HomeMarketBristol Myers wins FDA approval for Opdivo in first-line Hodgkin lymphoma Posted in MarketBristol Myers wins FDA approval for Opdivo in first-line Hodgkin lymphoma March 20, 2026 Reporter Bristol Myers wins FDA approval for Opdivo in first-line Hodgkin lymphoma Source link
Should I buy Nasdaq stock Marvell after Jensen Huang said it could be the next $1trn company? Posted by Reporter